STOCK TITAN

enVVeno Medical: Satterfield reports 4.8% stake

The reported position includes shares held through two entities and shares subject to a limited power of attorney.

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

enVVeno Medical Corp (NVNO) reported that reporting person Thomas A. Satterfield, Jr. beneficially owned 33,470 common shares, or 4.8% of the class. The percentage is based on 694,826 common shares outstanding as of October 29, 2026.

His reported sole voting and dispositive power was 8,464 shares; his shared voting and dispositive power was 25,006 shares.

Beneficially owned 33,470 shares Reported for Thomas A. Satterfield, Jr.
Percent of class 4.8% Beneficial ownership reported for Thomas A. Satterfield, Jr.
Common shares outstanding 694,826 shares As of October 29, 2026.
Sole voting and dispositive power 8,464 shares Reported for Thomas A. Satterfield, Jr.
Shared voting and dispositive power 25,006 shares Reported for Thomas A. Satterfield, Jr.
Shares held by Tomsat Investment & Trading Co., Inc. 5,714 shares Shares included in the beneficial ownership reported for Thomas A. Satterfield, Jr.
Shares held by Caldwell Mill Opportunity Fund, LLC 17,142 shares Shares included in the beneficial ownership reported for Thomas A. Satterfield, Jr.
Shares held by Rebecca A. Satterfield 2,150 shares Subject to Thomas A. Satterfield, Jr.'s limited power of attorney for voting and disposition.
Beneficially Owned regulatory
"Aggregate Amount Beneficially Owned by Each Reporting Person"
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
Sole Voting Power regulatory
"Sole Voting Power"
Sole voting power is the exclusive right to cast votes attached to a shareholder’s stock without needing approval from anyone else. Like holding the only remote control for a TV, it lets that holder decide corporate matters such as board members, mergers, and policy changes, making it important to investors because it concentrates control and can strongly influence a company’s strategy and the value of its shares.
Shared Dispositive Power regulatory
"Shared Dispositive Power"
limited power of attorney regulatory
"a limited power of attorney for voting and disposition purposes"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many NVNO shares does Thomas A. Satterfield, Jr. beneficially own?

Thomas A. Satterfield, Jr. reported beneficial ownership of 33,470 common shares, or 4.8% of the class. The percentage is based on 694,826 common shares outstanding as of October 29, 2026.

Which NVNO shares are held through entities or covered by a power of attorney?

5,714 shares are held by Tomsat Investment & Trading Co., Inc., which Mr. Satterfield wholly owns and leads as President. 17,142 shares are held by Caldwell Mill Opportunity Fund, LLC, a fund managed by an entity in which he owns a 50% interest and serves as Chief Investment Manager. He also has limited voting and disposition power of attorney over 2,150 shares held by Rebecca A. Satterfield, who has the right to receive or direct the proceeds from their sale.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G




Comment for Type of Reporting Person: *Based on 694,826 shares of common stock of the issuer (the "Common Stock") outstanding as of October 29, 2026, as reported by the issuer in its Quarterly Report on Form 10-Q for the fiscal quarter ended September 30, 2026.


SCHEDULE 13G



Thomas A. Satterfield, Jr.
Signature:/s/ Thomas A. Satterfield, Jr.
Name/Title:Thomas A. Satterfield, Jr.
Date:11/10/2026

Keep reading